1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Dental Implants & Abutments Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Dental Implants & Abutments Market, United States
3.1 Dental Implants & Abutments Market, United States, Revenue ($m), 2018-2033
3.1.1 Dental Abutments Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Dental Implants Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Dental Implants & Abutments Market, United States, Volume (Units), 2018-2033
3.2.1 Dental Abutments Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Dental Implants Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Dental Implants & Abutments Market, United States, Average Price ($) , 2018-2033
3.4 Dental Implants & Abutments Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Dental Implants & Abutments Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Dental Implants & Abutments Market
4.1 Nobel Biocare Services AG
4.1.1 Company Overview
4.2 Straumann Holding AG
4.2.1 Company Overview
4.3 Dentsply Sirona Inc
4.3.1 Company Overview
4.4 ZimVie Inc
4.4.1 Company Overview
4.5 Osstem Implant Co Ltd
4.5.1 Company Overview
5 Dental Implants & Abutments Market Pipeline Products6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Integer Holdings Acquires Pulse for USD140 Million
6.2 Debt Offerings
6.2.1 Stryker Raises USD600 Million in Public Offering of 4.850% Notes due 2028
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 12, 2024: Bittium Expands Its Range of Supported ECG Analysis Software by Collaborating With a Service Partner
7.1.2 Dec 11, 2023: FDA Accepts for Review Resubmitted NDA for TransCon PTH (Palopegteriparatide) in Adult Patients with Hypoparathyroidism
7.1.3 Nov 21, 2023: Ingeneron Announces Critical In-Depth Analysis of the Results From a Recently Published 480-Patient Phase III Knee Osteoarthritis Trial
7.1.4 Nov 02, 2023: Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member
7.1.5 Oct 13, 2023: Elos Medtech Notice to Attend the Extraordinary General Meeting
7.1.6 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
7.1.7 Sep 05, 2023: Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
7.1.8 Aug 22, 2023: Zimmer Biomet Announces Leadership Transition
7.2 Financial Announcements
7.2.1 Jul 08, 2024: Henry Schein to Webcast Second Quarter 2024 Conference Call on Tuesday, August 6, 2024 at 10:00 a.m. ET
7.2.2 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
7.2.3 May 02, 2024: Zimmer Biomet Announces First Quarter 2024 Financial Results
7.2.4 Jan 10, 2024: HemoSonics' Quantra Hemostasis System with QStat Cartridge Wins 2024 Business Intelligence Group (BIG) Innovation Award in Healthcare Category
7.2.5 Dec 12, 2023: Chemdiv Presented Data for FLT3 Clinical Candidate at the 65th ASH Annual Meeting and Exposition with its Partners and Sponsors
7.2.6 Nov 16, 2023: Alphamab : Preliminary Results of a Phase I Clinical Trial of JSKN003 in Australia for the Treatment of HER2- Expressing Advanced Solid Tumors
7.2.7 Oct 17, 2023: Amplifier Therapeutics, a Cambrian Bio Pipeline Company, Doses First Patients in Phase 1B Clinical Trial and Closes New Financing From Future Ventures
7.2.8 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
7.3 Government and Public Interest
7.3.1 May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024
7.3.2 Jan 03, 2024: Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference
7.3.3 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023
7.3.4 Oct 09, 2023: Stryker to Host Investor Day
7.3.5 Sep 07, 2023: Envista Announces Participation in Baird Global Healthcare Conference
7.3.6 Sep 05, 2023: Henry Schein to Present at Investor Conferences in September 2023
7.4 Legal And Regulatory
7.4.1 Aug 09, 2023: Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
7.5 Product News
7.5.1 Jun 24, 2024: Zygoma Implants as an Alternative Rehabilitation for Sever Atrophy Cases
7.6 Strategy And Business Planning
7.6.1 Sep 28, 2023: TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for In-Hospital BNCT at ASTRO 2023 Annual Meeting
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Dental Implants & Abutments Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Dental Abutments Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Dental Implants Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Dental Implants & Abutments Market, United States, Volume (Units), 2018-2033
Table 5: Dental Abutments Market, United States, Volume (Units), 2018-2033
Table 6: Dental Implants Market, United States, Volume (Units), 2018-2033
Table 7: Dental Implants & Abutments Market, United States, Average Price ($), 2018-2033
Table 8: Dental Implants & Abutments Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Dental Implants & Abutments Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Dental Implants & Abutments Market Pipeline Products
Table 11: Integer Holdings Acquires Pulse for USD140 Million
Table 12: Stryker Raises USD600 Million in Public Offering of 4.850% Notes due 2028
Table 13: Total Number of Primary Research Participants, Dental Devices Market, by Country
List of Figures
Figure 1: Dental Implants & Abutments Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Dental Abutments Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Dental Implants Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Dental Implants & Abutments Market, United States, Volume (Units), 2018-2033
Figure 5: Dental Abutments Market, United States, Volume (Units), 2018-2033
Figure 6: Dental Implants Market, United States, Volume (Units), 2018-2033
Figure 7: Dental Implants & Abutments Market, United States, Company Share (%) 2023